Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.
Also called NCT06196177
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 112 participants
- Registry
-
NCT06196177
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06196177. Randomized; single masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2025-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure
- Condition
- Heart Failure
- Condition
- Aortic Stenosis, Severe
- Intervention (Drug)
- Levosimontane injection
- Lead sponsor
- Qilu Hospital of Shandong University
Record details
- Record id
cardio:ct-nct06196177- Content hash
5eec686319bee4feafe3a748874e53c6b22024633bcf61653bb6ffa23c52116f